-
With ongoing concerns related to the possibility of thrombosis and death following implantation of a drug-eluting stents (DES), the sector has been focusing as much on follow-on drug therapy as the stent itself.
-
NEW YORK — Many of the largest cardiovascular device firms missed the late-November annual Piper Jaffray Health Care conference, but medium-sized and smaller companies more than made up for the big guys' absence from the lineup.
-
ATLANTA — At this year's annual meeting of the American Society for Hematology (Washington), the distinction of having an abstract selected for the scientific plenary session went to Amgen (Thousand Oaks, California).
-
Can a minimally invasive approach and a quicker patient recovery time following transmyocardial revascularization (TMR) via robotic assistance override some surgeons' ambivalence about the procedure?
-
Dennis Rosenberg has been named VP of marketing for Bacchus Vascular (Santa Clara, California).
-
Mechanical valves and tissue valves have always been tough competitors, both providing valuable, life-saving solutions for those with defective heart valves, but both having clear drawbacks.
-
oordinating care and reducing hospitalizations can lower Medicare costs, according to early results of a Centers for Medicare & Medicaid Services (CMS) study.
-
Opinion leaders from academia and research organizations; health care delivery; business, insurance and other health industry; and government and advocacy groups surveyed by the Commonwealth Fund say the U.S. health care system isn't designed to provide high-quality health care and changes must be made at the highest levels.
-
The House Energy and Commerce Committee is considering HR 2371, Deamonte's Law, which its sponsor says would establish a dental home for every American child by increasing dental services in community health centers and training more people in pediatric dentistry.
-
